Barbara Schüler

1.2k total citations
41 papers, 846 citations indexed

About

Barbara Schüler is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Barbara Schüler has authored 41 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Barbara Schüler's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (8 papers) and Lung Cancer Treatments and Mutations (5 papers). Barbara Schüler is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (8 papers) and Lung Cancer Treatments and Mutations (5 papers). Barbara Schüler collaborates with scholars based in United States, Germany and Norway. Barbara Schüler's co-authors include Jean L. Grem, Rebecca R. Thomas, Mary Quinn, Albrecht Reith, Nancy Harold, Gregory D. Leonard, Suzanne Fioravanti, M. A. Wright, H. R. Scherf and D. Schmähl and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Barbara Schüler

40 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Schüler United States 14 375 186 151 117 69 41 846
Robert H. Earhart United States 19 469 1.3× 354 1.9× 158 1.0× 52 0.4× 52 0.8× 45 1.1k
Chris Feierabend United States 14 364 1.0× 375 2.0× 129 0.9× 34 0.3× 51 0.7× 27 820
Yei Mei Peng United States 18 238 0.6× 386 2.1× 69 0.5× 95 0.8× 33 0.5× 22 968
María Sereno Spain 19 462 1.2× 405 2.2× 222 1.5× 97 0.8× 32 0.5× 62 1.1k
Paul V. Plourde United States 14 248 0.7× 209 1.1× 126 0.8× 78 0.7× 22 0.3× 26 995
Dennis Greenslade United Kingdom 7 365 1.0× 143 0.8× 81 0.5× 27 0.2× 32 0.5× 8 662
Huixin Yu Netherlands 17 334 0.9× 315 1.7× 255 1.7× 36 0.3× 83 1.2× 33 1.1k
Qing Lü China 18 268 0.7× 414 2.2× 126 0.8× 30 0.3× 133 1.9× 36 1.3k
John A. Benvenuto United States 14 279 0.7× 226 1.2× 76 0.5× 38 0.3× 33 0.5× 33 589
Anne-Charlotte Dubbelman Netherlands 17 428 1.1× 386 2.1× 109 0.7× 36 0.3× 37 0.5× 42 942

Countries citing papers authored by Barbara Schüler

Since Specialization
Citations

This map shows the geographic impact of Barbara Schüler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Schüler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Schüler more than expected).

Fields of papers citing papers by Barbara Schüler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Schüler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Schüler. The network helps show where Barbara Schüler may publish in the future.

Co-authorship network of co-authors of Barbara Schüler

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Schüler. A scholar is included among the top collaborators of Barbara Schüler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Schüler. Barbara Schüler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kadioglu, Onat, Janine Naß, Mohamed E.M. Saeed, Barbara Schüler, & Thomas Efferth. (2015). Kaempferol Is an Anti-Inflammatory Compound with Activity towards NF-κB Pathway Proteins.. PubMed. 35(5). 2645–50. 69 indexed citations
3.
Schüler, Barbara. (2014). Environmental and climate change in South and Southeast Asia : how are local cultures coping?. BRILL eBooks. 6 indexed citations
4.
Schüler, Barbara. (2014). Environmental and Climate Change in South and Southeast Asia. 9 indexed citations
5.
Schüler, Barbara. (2013). Stifter und Mäzene und ihre Rolle in der Religion : von Königen, Mönchen, Vordenkern und Laien in Indien, China und anderen Kulturen. Harrassowitz eBooks. 2 indexed citations
6.
Markschies, Christoph, et al.. (2010). Erinnerungsorte des Christentums. C.H.Beck eBooks. 4 indexed citations
7.
Hassan, Raffit, Charles Schweizer, Barbara Schüler, et al.. (2009). Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy. Lung Cancer. 68(3). 455–459. 61 indexed citations
8.
Schüler, Barbara, Tobias Vrede, Katarina Andreasen, et al.. (2008). Screening for Anti-Inflammatory Activity of 12Arnica(Asteraceae) Species Assessed by Inhibition of NF-κB and Release of Human Neutrophil Elastase. Planta Medica. 74(15). 1789–1794. 17 indexed citations
9.
Leonard, Gregory D., M. A. Wright, Mary Quinn, et al.. (2005). Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer. 5(1). 116–116. 135 indexed citations
10.
Thomas, Rebecca R., Mary Quinn, Barbara Schüler, & Jean L. Grem. (2003). Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer. 97(9). 2301–2307. 91 indexed citations
11.
Harold, Nancy, Muhammad Wasif Saif, Barbara Schüler, et al.. (2003). Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule. Cancer Chemotherapy and Pharmacology. 52(1). 79–85. 13 indexed citations
12.
Breathnach, Oscar S., Vijay Kasturi, Frederic J. Kaye, et al.. (2002). Phase II Neoadjuvant Trial of Paclitaxel by 96-Hour Continuous Infusion (CIVI) in Combination With Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non–Small-Cell Lung Cancer. American Journal of Clinical Oncology. 25(3). 269–273. 2 indexed citations
13.
Keith, Bruce, Suzanne Zentko, Nancy Harold, et al.. (2002). Impact of two weekly schedules of oral eniluracil given with fluorouracil and leucovorin on the duration of dihydropyrimidine dehydrogenase inhibition.. PubMed. 8(5). 1045–50. 4 indexed citations
14.
15.
Schüler, Barbara. (2000). "Im Geiste der Gemordeten...": Die "Weisse Rose" und ihre Wirkung in der Nachkriegszeit. Ferdinand Schöningh eBooks. 1 indexed citations
16.
Schüler, Barbara, Judith Brown, Seth M. Steinberg, et al.. (1997). Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer.. Journal of Clinical Oncology. 15(2). 735–743. 23 indexed citations
17.
Schüler, Barbara, et al.. (1996). Four-day paclitaxel infusion with cisplatin for patients with lung cancer. Lung Cancer. 14(1). 170–170. 5 indexed citations
18.
Gescheidt, Georg, Jürgen Heınze, Barbara Schüler, et al.. (1992). Electron‐Transfer‐Catalyzed cis → trans Isomerization of 1,1′‐Azonorborane. Prototype of a reversible two‐stage storage system. Helvetica Chimica Acta. 75(5). 1607–1612. 11 indexed citations
19.
Farrants, George, et al.. (1989). Characterization of the Morphological Properties of Welding Fume Particles by Transmission Electron Microscopy and Digital Image Analysis. American Industrial Hygiene Association Journal. 50(9). 473–479. 8 indexed citations
20.
Farrants, George, et al.. (1988). A simple, direct method for the collection of particles from air samples for transmission electron microscopy and digital image analysis. Journal of Microscopy. 149(2). 159–164. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert H. Earhart Breakdown of academic impact, for papers by Chris Feierabend Breakdown of academic impact, for papers by Yei Mei Peng Breakdown of academic impact, for papers by María Sereno Breakdown of academic impact, for papers by Paul V. Plourde Breakdown of academic impact, for papers by Dennis Greenslade Breakdown of academic impact, for papers by Huixin Yu Breakdown of academic impact, for papers by Qing Lü Breakdown of academic impact, for papers by John A. Benvenuto Breakdown of academic impact, for papers by Anne-Charlotte Dubbelman
Rankless by CCL
2026